A Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Anti-TNF(Alpha) Refractory Participants With Active Radiographic Axial Spondyloarthritis
Clinical trial NCT02438787 · TERMINATED
Trial details
- NCT number
- NCT02438787
- Sponsor
- Janssen Research & Development, LLC
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-31
- Primary completion
- 2017-08-31
- Enrollment
- 315
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.